Nephrogenous cyclic GMP production during NaCl loading and ANP infusion. 1990

Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

To further study the mechanisms of the renal effects of ANP, we examined the effects of NaCl loading and ANP infusion on nephrogenous cGMP production. Six normotensives (NTs) and 7 essential hypertensives (HTs) were placed on 7-day low (3 g/day) and then 7-day high NaCl diets (20 g/day). On the last day of each period, the natriuretic and nephrogenous cGMP responses to ANP infusion at 25 ng/kg/min for 40 min were determined. ANP infusion markedly increased the plasma concentrations of ANP and cGMP and the urinary excretions of Na and cGMP. These changes were accompanied by a rise in nephrogenous cGMP. Increases in nephrogenous cGMP during ANP infusion were not different between HTs and NTs despite a greater natriuretic response in HTs. NaCl loading significantly increased the natriuretic response to ANP infusion in both groups. However, nephrogenous cGMP production induced by ANP infusion was not affected by changes in NaCl intake. Thus, although ANP-induced natriuresis is associated with an increase in nephrogenous cGMP, the natriuretic effect of ANP seems to be modified to a greater extent by indirect mechanisms such as renal perfusion pressure and body fluid volume status.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
February 1992, Acta physiologica Scandinavica,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
September 2003, Japanese heart journal,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
January 1989, Advances in experimental medicine and biology,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
January 1991, Acta astronautica,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
January 1981, Recent progress in hormone research,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
June 1993, European journal of clinical investigation,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
December 1985, Klinische Wochenschrift,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
September 1988, Klinische Wochenschrift,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
January 1985, Journal of cyclic nucleotide and protein phosphorylation research,
Y Hirata, and K Fukui, and H Hayakawa, and S Namba, and T Ishimitsu, and T Sugimoto, and K Kimura, and H Matsuoka, and T Sugimoto
April 1990, Biochemical and biophysical research communications,
Copied contents to your clipboard!